Press release
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D Immunoglobulin, TPO-RA) And Segment Forecasts To 2025
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics
Global idiopathic thrombocytopenic purpura (ITP) therapeutics market is expected to reach USD 675.5 million by 2025. Rising R&D leading to the introduction of new drugs for IVIG and TPO-RA classes is expected to propel growth over the forecast period. In addition, government regulation such as the Orphan Drug Act in the United States with an aim to encourage new product development is projected to fuel growth.
The industry is characterized by rising demand for combination therapies as they exhibit higher efficiency as compared to other treatments. Moreover, they are cost efficient and help curb side effects associated with individual therapeutic classes. Some of the major combination therapies are dexamethasone and rituximab, dexamethasone and TPO-RA, IVIG and corticosteroids. Splenectomy, the procedure to remove spleen is aimed at reducing the amount of anti-platelet antibodies, is expected to fuel demand.
Visit on the below link to get a sample of report@ https://bit.ly/2kCJoPt
Idiopathic thrombocytopenic purpura is an autoimmune disorder clinically diagnosed as acquired bleeding disorder in which platelets (blood cells) are destroyed by immune system, who play an important role in primary and secondary haemostasis. Idiopathic thrombocytopenic purpura is characterised by tendency to bleed continuously mostly from extremities such as nose and gums, purpuric rash and petechiae. Individuals with idiopathic thrombocytopenic purpura have platelet count below normal (less than 150,000 cells/mm3) causing thrombocytopenia. Idiopathic thrombocytopenic purpura can be acute for chronic with platelet count less than 150,000 cells/mm3 and 50,000 cells/mm3 respectively. In fatal or sever idiopathic thrombocytopenic purpura intracerebral or subarachnoid hemorrhage, lower gastrointestinal bleeding or other internal bleeding may occur.In idiopathic thrombocytopenic purpura activation of lymphocytes leads to anti-platelet antibodies against the fibrinogen receptor i.e platelet glycoproteins IIb/IIIa. Incidence of idiopathic thrombocytopenic purpura in children and adult population is approximately 50 and 66 cases per 1,000,000 per year respectively.
Commonly utilised tests for diagnosis of idiopathic thrombocytopenic purpura include blood typing, blood count, direct Coombs testing, evaluation of peripheral smear, bone marrow evaluation, immunoglobulin quantitation and evaluation for platelet antibodies. More advanced tests may be performed such as platelet binding assay, genetic mutational analysis and bone marrow cultures for megakaryocyte growth and differentiation. Testing of H. pylori infection is considered as a standard diagnostic test for individuals suspected of idiopathic thrombocytopenic purpura, in countries with higher incidence of H. pylori infection. Treatment for idiopathic thrombocytopenic purpura mainly aims for normal platelet count to prevent excessive bleeding. First line therapy generally used in of idiopathic thrombocytopenic purpura is oral corticosteroids, such as prednisone, rituximab, azathioprine, eltrombopag, methylprednisolone etc. Second line treatment generally used is spleenectomy while new treatment measures include intravenous immunoglobulin (IVIG), anti-D immunoglobulin and thrombopoietin receptor agonists (TPO-RA).
Key Players
Some of the key players in idiopathic thrombocytopenic purpura market include GlaxoSmithKline, Amgen. Inc, Grifols S.A, CSL Behring, Baxter, Sandoz, Contract Pharmacal, Roxane and others.
Browse full report with Table of Content@ https://www.qyresearchgroups.com/report/global-idiopathic-thrombocytopenic-purpura-itp-therapeutics-market-size-status-and-forecast-2025
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Corticosteroids
Intravenous Immunoglobulin (IVIG)
Anti-D Immunoglobulin
Thrombopoietin Receptor Agonists (TPO-RA)
Others
Market segment by Application, Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics can be split into
Hospitals & Clinics
Long-term Care Units
Home Care
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Visit on the below link to get a sample of report@ https://bit.ly/2kCJoPt
TOC:
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, Status and Forecast 2025
1 Industry Overview of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics
1.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Overview
1.1.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by Type
1.3.1 Corticosteroids
1.3.2 Intravenous Immunoglobulin (IVIG)
1.3.3 Anti-D Immunoglobulin
1.3.4 Thrombopoietin Receptor Agonists (TPO-RA)
1.3.5 Others
1.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by End Users/Application
1.4.1 Hospitals & Clinics
1.4.2 Long-term Care Units
1.4.3 Home Care
2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Competition Analysis by Players
2.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GSK (UK)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Amgen Inc. (US)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Grifols Biologicals Inc. (Spain)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Eisai (Japan)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 F.Hoffman-La Roche (Switzerland)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type and Application (2013-2018)
4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2013-2018)
4.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in Future
4.4 Top Consumer/End Users of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics
5 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Development Status and Outlook
5.1 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2013-2018)
5.2 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2013-2018)
Make An Enquiry@ https://www.qyresearchgroups.com/send-an-enquiry/962776
About Us:
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.
Contact us:
Email- sales@qyresearchgroups.com
Web- https://www.qyresearchgroups.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D Immunoglobulin, TPO-RA) And Segment Forecasts To 2025 here
News-ID: 1066951 • Views: …
More Releases from QY Research Groups
Sanitary Pads Market Growth Statistics and Key Players Insights: P&G, Kimberly C …
A sanitary pad is an absorbent item worn by women who are menstruating, bleeding after giving birth, recovering from gynecologic surgery, experiencing a miscarriage or abortion, or in any other situation where it is necessary to absorb a flow of blood from the vagina.
The Sanitary Pads report is an exclusive elaborated study of the given industry with an aim towards the global market trend. The report focuses to deliver a…
Thermoplastic Hose Market 2019 Analysis The Global Key Players: Kurt Hydraulics, …
The global analysis report titled as Thermoplastic Hose Market has recently published by QY Research Groups to its huge repository which helps to make informed decisions in the businesses. It includes a comprehensive analysis of the market. This research report throws light on historical records, existing market scenario and future predictions of market growth. Primary and secondary research methodologies have been used for examining the global Thermoplastic Hose Market. It…
Pallet Pooling Market 2019 SWOT Analysis By Players; Brambles Limited, Buckhorn, …
The global analysis report titled as Pallet Pooling Market has recently published by QY Research Groups to its huge repository which helps to make informed decisions in the businesses. It includes a comprehensive analysis of the market. This research report throws light on historical records, existing market scenario and future predictions of market growth. Primary and secondary research methodologies have been used for examining the global Pallet Pooling Market. It…
Manufactured Housing Market 2019 SWOT Analysis By Major Eminent Players; Clayton …
The global analysis report titled as Manufactured Housing Market has recently published by QY Research Groups to its huge repository which helps to make informed decisions in the businesses. It includes a comprehensive analysis of the market. This research report throws light on historical records, existing market scenario and future predictions of market growth. Primary and secondary research methodologies have been used for examining the global Manufactured Housing Market. It…
More Releases for Idiopathic
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth …
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In…
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, …
Global Idiopathic Scoliosis Treatment Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatment Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sample…
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, it…
Juvenile Idiopathic Arthritis Therapeutics Market
JIA is also known as juvenile idiopathic arthritis and is the most common inflammatory arthritis of childhood, musculoskeletal pain is a common symptom in childhood and is usually benign and self-resolving. JIA is affected to children who are under age 17. Recognizing rare but treatable causes, including inflammatory, malignant and infectious etiologies, remains a constant challenge. According to the American College of Rheumatology, Juvenile idiopathic arthritis affects one in 1000…
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
